Skip to main content
Top
Published in: Seminars in Immunopathology 3/2007

01-09-2007 | Introduction

The NLR-related disorders

Author: Michael McDermott

Published in: Seminars in Immunopathology | Issue 3/2007

Login to get access

Excerpt

The present issue, which is dedicated to the NOD-like receptors (NLRs), is particularly timely since there is burgeoning evidence that these molecules play a pivotal role in an expanding number of monogenic and polygenic disease. At the molecular level the NLR family of molecules plays a key role as pattern recognition receptors for intracellular bacterial constituents, toxins and also sensing cellular metabolic stress by an array of mechanisms. Several of the NLR- related molecules form integral components of a multimeric protein complex, termed the inflammasome, as first described in 2002 by Martinon et al.; this fundamental discovery has been subsequently translated into many clinical applications, as described in this edition. Other closely related multimeric molecular platforms, such as the Nodosome, which is involved in the control of bacterial infections and inflammation, have also been described. …
Metadata
Title
The NLR-related disorders
Author
Michael McDermott
Publication date
01-09-2007
Publisher
Springer-Verlag
Published in
Seminars in Immunopathology / Issue 3/2007
Print ISSN: 1863-2297
Electronic ISSN: 1863-2300
DOI
https://doi.org/10.1007/s00281-007-0086-z

Other articles of this Issue 3/2007

Seminars in Immunopathology 3/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.